Acadia Pharmaceuticals Inc (ACAD)

Is Acadia Pharmaceuticals Inc (ACAD) A Buy Now?

According to our latest analysis, ACAD could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 12 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ACAD, as trading bearish markets can be challenging and may result in losses.

1. RSI (Relative Strength Index): The RSI(14) value of 42.04 indicates that ACAD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
2. STOCH (Stochastic Oscillator): The STOCH value of 35.67 indicates that ACAD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 56.77 indicates that ACAD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
4. ADX (Average Directional Index): The ADX value of 33.73 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
5. CCI (Commodity Channel Index): A CCI(14) value of -76.37 indicates that ACAD is still oversold but not to an extreme extent.

Long-term ACAD price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Acadia Pharmaceuticals Inc financial reports and earnings history, Acadia Pharmaceuticals Inc (ACAD) stock could reach $24.84 by 2030, $32.80 by 2040 and $19.88 by 2050. See the projected annual prices until 2050 of the Acadia Pharmaceuticals Inc stock below:

• Acadia Pharmaceuticals Inc (ACAD) is expected to reach an average price of $16.49 in 2035, with a high prediction of $28.50 and a low estimate of $13.36. This indicates an -12.05% change from the last recorded price of $18.75.
• Acadia Pharmaceuticals Inc (ACAD) stock is projected to chart a bullish course in 2040, with an average price target of $15.86, representing an -15.40% change from its current level. The forecast ranges from a conservative $14.97 to a sky-high $32.80.
• Our analysts predict Acadia Pharmaceuticals Inc (ACAD) to change +7.16% by 2045, soaring from $12.86 to an average price of $20.09, potentially reaching $32.40. While $12.86 is the low estimate, the potential upside is significant.
• Acadia Pharmaceuticals Inc (ACAD) stock is expected to climb by 2050, reaching an average of $18.35, a -2.13% change from its current level. However, a wide range of estimates exists, with high and low targets of $19.88 and $10.25, respectively, highlighting the market's uncertainty.

Acadia Pharmaceuticals Inc Stock (ACAD) Year by Year Forecast